Trial · NCT04064411
Adverse events140
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 140
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Administration site erythema | General disorders | Abaloparatide-SC | 4 | 254 | 4 |
| other | Administration site erythema | General disorders | Abaloparatide-sMTS | 13 | 252 | 13 |
| other | Application site discolouration | General disorders | Abaloparatide-SC | 0 | 254 | 0 |
| other | Application site discolouration | General disorders | Abaloparatide-sMTS | 37 | 252 | 37 |
| other | Application site erythema | General disorders | Abaloparatide-SC | 15 | 254 | 15 |
| other | Application site erythema | General disorders | Abaloparatide-sMTS | 190 | 252 | 205 |
| other | Application site haemorrhage | General disorders | Abaloparatide-SC | 2 | 254 | 2 |
| other | Application site haemorrhage | General disorders | Abaloparatide-sMTS | 73 | 252 | 78 |
| other | Application site oedema | General disorders | Abaloparatide-SC | 1 | 254 | 1 |
| other | Application site oedema | General disorders | Abaloparatide-sMTS | 122 | 252 | 128 |
| other | Application site pain | General disorders | Abaloparatide-SC | 14 | 254 | 23 |
| other | Application site pain | General disorders | Abaloparatide-sMTS | 142 | 252 | 289 |
| other | Application site pruritus | General disorders | Abaloparatide-SC | 10 | 254 | 10 |
| other | Application site pruritus | General disorders | Abaloparatide-sMTS | 83 | 252 | 87 |
| other | Application site reaction | General disorders | Abaloparatide-SC | 0 | 254 | 0 |
| other | Application site reaction | General disorders | Abaloparatide-sMTS | 18 | 252 | 20 |
| other | Application site swelling | General disorders | Abaloparatide-SC | 6 | 254 | 6 |
| other | Application site swelling | General disorders | Abaloparatide-sMTS | 116 | 252 | 124 |
| other | Application site vesicles | General disorders | Abaloparatide-SC | 1 | 254 | 1 |
| other | Application site vesicles | General disorders | Abaloparatide-sMTS | 16 | 252 | 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04064411/events